You are using an older browser version. Please use a supported version for the best MSN experience.

TENAX THERAPEUTICS, INC.

NASDAQ: TENX
0.9799
+0.0349
+3.69%

Sector

Healthcare

Industry

Biotechnology & Medical Research

Tenax Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing products for the critical care market. The Company's main product is levosimendan. Levosimendan is a calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure. Levosimendan represents therapeutic modalities for the treatment of Low Cardiac Output Syndrome (LCOS), septic shock and other critical care conditions. The therapeutic effects of levosimendan are mediated through increased cardiac contractility by calcium sensitization of troponin C, resulting in a positive inotropic effect, which is not associated with substantial increases in oxygen demand; opening of potassium channels in the vasculature smooth muscle, resulting in a vasodilatory effect on all vascular beds, and opening of mitochondrial potassium channels in cardiomyocytes, resulting in a cardioprotective effect.

Key People

Ronald Ray Blanck

Independent Chairman of the Board

Michael B. Jebsen

President, Chief Financial Officer

Anthony DiTonno

Chief Executive Officer, Director

Douglas Hay

Executive Vice President - Regulatory Affairs

Doug Randall

Executive Vice President - Business and Commercial Operations

  • Tenax Therapeutics Inc

  • 1 Copley Pkwy Ste 490

  • MORRISVILLE, NC 27560-9693

  • US.Map

  • Phone: +1 919 8064414

  • Fax: +1 302 6745266

  • tenaxthera.com

Incorporated

2008

Employees

9

Insider Trades
  • Recent
  • All
  • Date

  • Name

  • Transaction

  • Shares

  • Price(s)

  • Value

    • 5/18/2020

    • BLANCK RONALD R

    • Bought

    • 5,000

    • 0.95

    • 4,774.00

    • Date

    • Name

    • Transaction

    • Shares

    • Price(s)

    • Value

      • 5/18/2020

      • BLANCK RONALD R

      • Bought

      • 5,000

      • 0.95

      • 4,774.00

      AdChoices
      AdChoices
      AdChoices
      image beaconimage beaconimage beacon